产品名称 | NebuSelect™ Recombinant Human Factor H/CFH, His-tag |
---|---|
目录号 | NBL-242814 |
别名 | Factor H/CFH; Complement factor H; H factor 1; CFH; HF; HF1; HF2; AHUS1; AMBP1; ARMD4; ARMS1; CFHL3; FH; FHL1; HUS |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P08603-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242814-100ug | 100ug | Inquire | Inquire | |
NBL-242814-1mg | 1mg | Inquire | Inquire | |
NBL-242814-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Factor H/CFH, His-tag
Catalog#:
NBL-242814
Description:
NebuSelect™ Recombinant Human Factor H/CFH, His-tag(Cat#NBL-242814) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser860-Arg1231.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 42.8 kDa. Due to glycosylation, the protein migrates to 60-68 kDa based on Bis-Tris PAGE result.
Target Name:
Factor H/CFH; Complement factor H; H factor 1; CFH; HF; HF1; HF2; AHUS1; AMBP1; ARMD4; ARMS1; CFHL3; FH; FHL1; HUS
Target Information:
Factor H is the major soluble inhibitor of complement, where its binding to self markers (i.e., particular glycan structures) prevents complement activation and amplification on host surfaces. Not surprisingly, mutations and polymorphisms that affect recognition of self by factor H are associated with diseases of complement dysregulation, such as age-related macular degeneration and atypical haemolytic uremic syndrome. In addition, pathogens (i.e., non-self) and cancer cells (i.e., altered-self) can hijack factor H to evade the immune response.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.